Pharmacokinetics (PK) of 2 dosing regimens of palifermin in patients (Pts) with hematologic malignancies (HM) undergoing high-dose chemoradiotherapy and hematopoietic stem cell transplantation (HSCT)
P. Zia-Amirhosseini, M. Salfi, D. Elhardt, J. Aycock, T.C. Cheah, A. Cesano, D.D. HurdVolume:
12
Year:
2006
Language:
english
DOI:
10.1016/j.bbmt.2005.11.291
File:
PDF, 66 KB
english, 2006